PO.6.135 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and phase II study design in patients with SLE and/or CLE (WILLOW)
| Autor: | F Moreau, S Roy, M Khursheed, A Deshpande, C Vazquez-Mateo, EF Morand, VP Werth, A Bender, A Deshmukh, B Vaidyanathan, M Przetak, DR Pearson |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022) |
| Druh dokumentu: | article |
| ISSN: | 2053-8790 |
| DOI: | 10.1136/lupus-2022-elm2022.156 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|